Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland

Table 3 Prevalence of hypnotics/anxiolytics prescriptions

Age groups	Patients prescribed hypnotics/anxiolytics			Prevalence of hypnotics/anxiolytics use (%)
Age groups	All	Men	Women	All	Men	Women
<1–19	848	389	459	1.4	1.3	1.5
20–29	2,748	994	1,754	8.0	6.2	9.6
30–39	4,071	1,480	2,591	12.2	9.0	15.3
40–49	4,881	1,626	3,255	17.7	12.0	23.0
50–59	6,154	2,094	4,060	24.3	16.9	31.5
60–69	5,382	1,938	3,444	28.1	20.7	35.1
70–79	3,948	1,388	2,560	35.4	26.7	42.9
80+	2,894	1,013	1,881	28.9	24.7	31.9
Total	30,926	10,922	20,004	13.9	10.1	17.5

Prevalence of hypnotics/anxiolytics prescriptions in primary care stratified by age and sex during the period 1 Jan 2009 to 31 Dec 2012. The total number of patients is shown in Table 2

ISSN: 2731-4553